PARAMUS, N.J., July 8, 2026 /PRNewswire/ — On July 2, 2026, the U.S. Food and Drug Administration (FDA) approved the use of wilate® (von Willebrand Factor/Coagulation Factor VIII Complex [Human]) for routine prophylaxis to reduce the frequency of bleeding episodes in pediatric patients…
Source: prnewswire
Country: United States